1-8 of 8
Caterina Vivaldi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lenvatinib versus Sorafenib Second-Line Therapy in Patients with Hepatocellular Carcinoma Progressed to Atezolizumab plus Bevacizumab: A Retrospective Real-World Study

Available to Purchase
Subject Area:
Oncology
Mara Persano, Andrea Casadei-Gardini, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Federico Rossari, Changhoon Yoo, Jaekyung Cheon, Fabian Finkelmeier, Ho Yeong Lim, José Presa, Gianluca Masi, Francesca Bergamo, Elisabeth Amadeo, Francesco Vitiello, Takashi Kumada, Naoya Sakamoto, Hideki Iwamoto, Tomoko Aoki, Hong Jae Chon, Vera Himmelsbach, Massimo Alberto Iavarone, Giuseppe Cabibbo, Margarida Montes, Francesco Giuseppe Foschi, Caterina Vivaldi, Caterina Soldà, Takuya Sho, Takashi Niizeki, Naoshi Nishida, Christoph Steup, Mariangela Bruccoleri, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Noritomo Shimada, Kazuhito Kawata, Atsushi Hiraoka, Fujimasa Tada, Hideko Ohama, Kazuhiro Nouso, Asahiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Michitaka Imai, Hisashi Kosaka, Atsushi Naganuma, Yohei Koizumi, Shinichiro Nakamura, Masaki Kaibori, Hiroko Iijima, Yoichi Hiasa, Luigi Mascia, Silvia Foti, Silvia Camera, Fabio Piscaglia, Mario Scartozzi, Stefano Cascinu, Margherita Rimini
Journal: Oncology
Oncology (2025) 103 (6): 456–468.
https://doi.org/10.1159/000541018
Published Online: 11 October 2024
View articletitled, Lenvatinib versus Sorafenib Second-Line Therapy in Patients with Hepatocellular Carcinoma Progressed to Atezolizumab plus Bevacizumab: A Retrospective Real-World Study
Open the PDF for Lenvatinib versus Sorafenib Second-Line Therapy in Patients with Hepatocellular Carcinoma Progressed to Atezolizumab plus Bevacizumab: A Retrospective Real-World Study in another window
Journal Articles

Mismatch Repair Deficiency in Biliary Tract Cancer: Prognostic Implications and Correlation with Histology

Free
Subject Area:
Oncology
Caterina Vivaldi, Virginia Genovesi, Clara Ugolini, Laura Bernardini, Andrea Casadei-Gardini, Vincenzo Formica, Francesca Salani, Giulia Orsi, Valentina Massa, Andrea Cacciato-Insilla, Miriam Caccese, Silvia Cesario, Kalliopi Andrikou, Jessica Graziani, Daniela Campani, Enrico Vasile, Gabriella Fontanini, Lorenzo Fornaro, Gianluca Masi
Journal: Oncology
Oncology (2024) 102 (2): 157–167.
https://doi.org/10.1159/000533406
Published Online: 12 September 2023
View articletitled, Mismatch Repair Deficiency in Biliary Tract Cancer: Prognostic Implications and Correlation with Histology
Open the PDF for Mismatch Repair Deficiency in Biliary Tract Cancer: Prognostic Implications and Correlation with Histology in another window
Journal Articles

Dynamic Profiling of the Immune Tumor Microenvironment in Locally Advanced Gastric Cancer Treated with Perioperative Chemotherapy

Available to Purchase
Subject Area:
Topic Article Package: ADC (Antibody-Drug Conjugates) , Karger e-Journal Backfile Collection 2023 , Oncology
Irene Pecora, Clara Ugolini, Riccardo Giannini, Mirella Giordano, Caterina Vivaldi, Monica Lencioni, Stefano Santi, Valentina Massa, Giovanni Pallabazzer, Silvia Catanese, Francesca Salani, Mario Antonio Belluomini, Enrico Vasile, Chiara Cremolini, Gabriella Fontanini, Gianluca Masi, Lorenzo Fornaro
Journal: Oncology
Oncology (2023) 101 (7): 435–445.
https://doi.org/10.1159/000530853
Published Online: 12 June 2023
View articletitled, Dynamic Profiling of the Immune Tumor Microenvironment in Locally Advanced Gastric Cancer Treated with Perioperative Chemotherapy
Open the PDF for Dynamic Profiling of the Immune Tumor Microenvironment in Locally Advanced Gastric Cancer Treated with Perioperative Chemotherapy in another window
Journal Articles

Role of the Prognostic Nutritional Index in Predicting Survival in Advanced Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab

Free
Subject Area:
Karger e-Journal Backfile Collection 2023 , Oncology
Mara Persano, Margherita Rimini, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Jaekyung Cheon, Fabian Finkelmeier, Ho Yeong Lim, José Presa, Gianluca Masi, Changhoon Yoo, Sara Lonardi, Bernardo Stefanini, Takashi Kumada, Naoya Sakamoto, Hideki Iwamoto, Tomoko Aoki, Hong Jae Chon, Vera Himmelsbach, Margarida Montes, Caterina Vivaldi, Caterina Soldà, Atsushi Hiraoka, Takuya Sho, Takashi Niizeki, Naoshi Nishida, Christoph Steup, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Noritomo Shimada, Kazuhito Kawata, Fujimasa Tada, Hideko Ohama, Kazuhiro Nouso, Asahiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Taeang Arai, Michitaka Imai, Hisashi Kosaka, Atsushi Naganuma, Yohei Koizumi, Shinichiro Nakamura, Masaki Kaibori, Hiroko Iijima, Yoichi Hiasa, Valentina Burgio, Angelo Della Corte, Francesca Ratti, Francesco De Cobelli, Luca Aldrighetti, Mario Scartozzi, Stefano Cascinu, Andrea Casadei-Gardini
Journal: Oncology
Oncology (2023) 101 (5): 283–291.
https://doi.org/10.1159/000528818
Published Online: 19 January 2023
View articletitled, Role of the Prognostic Nutritional Index in Predicting Survival in Advanced Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab
Open the PDF for Role of the Prognostic Nutritional Index in Predicting Survival in Advanced Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab in another window
Journal Articles

Effects of Metformin and Vitamin D on Clinical Outcome in Cholangiocarcinoma Patients

Available to Purchase
Subject Area:
Oncology
Andrea Casadei-Gardini, Roberto Filippi, Margherita Rimini, Ilario Giovanni Rapposelli, Lorenzo Fornaro, Nicola Silvestris, Luca Aldrighetti, Giacomo Aimar, Giulia Rovesti, Giulia Bartolini, Caterina Vivaldi, Oronzo Brunetti, Elisa Sperti, Rosa La Face, Francesca Ratti, Kalliopi Andrikou, Martina Valgiusti, Laura Bernardini, Antonella Argentiero, Elisabetta Fenocchio, Giovanni Luca Frassineti, Silvia Cesario, Francesco Giovannelli, Virginia Quarà, Francesco Leone, Stefano Cascinu
Journal: Oncology
Oncology (2021) 99 (5): 292–299.
https://doi.org/10.1159/000512796
Published Online: 24 February 2021
View articletitled, Effects of Metformin and Vitamin D on Clinical Outcome in Cholangiocarcinoma Patients
Open the PDF for Effects of Metformin and Vitamin D on Clinical Outcome in Cholangiocarcinoma Patients in another window
Journal Articles

Third-Line Chemotherapy with Irinotecan plus 5-Fluorouracil in Caucasian Metastatic Gastric Cancer Patients

Available to Purchase
Subject Area:
Oncology
Giulia Pasquini, Enrico Vasile, Chiara Caparello, Caterina Vivaldi, Gianna Musettini, Monica Lencioni, Iacopo Petrini, Lorenzo Fornaro, Alfredo Falcone
Journal: Oncology
Oncology (2016) 91 (6): 311–316.
https://doi.org/10.1159/000443962
Published Online: 06 October 2016
View articletitled, Third-Line Chemotherapy with Irinotecan plus 5-Fluorouracil in Caucasian Metastatic Gastric Cancer Patients
Open the PDF for Third-Line Chemotherapy with Irinotecan plus 5-Fluorouracil in Caucasian Metastatic Gastric Cancer Patients in another window
Journal Articles

Topoisomerase 1 Promoter Variants and Benefit from Irinotecan in Metastatic Colorectal Cancer Patients

Available to Purchase
Subject Area:
Oncology
Elisa Paolicchi, Caterina Vivaldi, Veronica De Gregorio, Francesco Crea, Lorenzo Fornaro, Gianluca Masi, Fotios Loupakis, Francesco Graziano, Monica Ronzoni, Vincenzo Ricci, Alfredo Falcone, Romano Danesi
Journal: Oncology
Oncology (2016) 91 (5): 283–288.
https://doi.org/10.1159/000448004
Published Online: 31 August 2016
View articletitled, Topoisomerase 1 Promoter Variants and Benefit from Irinotecan in Metastatic Colorectal Cancer Patients
Open the PDF for Topoisomerase 1 Promoter Variants and Benefit from Irinotecan in Metastatic Colorectal Cancer Patients in another window
Journal Articles

Identification of Responders to Sorafenib in Hepatocellular Carcinoma: Is Tumor Volume Measurement the Way Forward?

Available to Purchase
Subject Area:
Oncology
Irene Bargellini, Alessandra Scionti, Valeria Mismas, Gianluca Masi, Caterina Vivaldi, Carlo Bartolozzi, Rodolfo Sacco
Journal: Oncology
Oncology (2014) 86 (4): 191–198.
https://doi.org/10.1159/000358599
Published Online: 30 April 2014
View articletitled, Identification of Responders to Sorafenib in Hepatocellular Carcinoma: Is Tumor Volume Measurement the Way Forward?
Open the PDF for Identification of Responders to Sorafenib in Hepatocellular Carcinoma: Is Tumor Volume Measurement the Way Forward? in another window